{
    "clinical_study": {
        "@rank": "161364", 
        "acronym": "MACH", 
        "arm_group": [
            {
                "arm_group_label": "Minocycline", 
                "arm_group_type": "Experimental", 
                "description": "This arm will receive a total of 5 doses of minocycline. There will be 1 dose of intravenous minocycline followed by 4 doses of oral (pill) minocycline. Each dose is 24 hours apart."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "This arm will not receive any minocycline"
            }
        ], 
        "brief_summary": {
            "textblock": "The MACH Trial is a pilot study of 400mg minocycline over five days in acute intracerebral\n      hemorrhage patients. The study will evaluation the safety and efficacy of minocycline in\n      intracerebral hemorrhage patients."
        }, 
        "brief_title": "A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Intracerebral Hemorrhage", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Cerebral Hemorrhage"
            ]
        }, 
        "detailed_description": {
            "textblock": "MACH is a randomized trial of minocycline in intracerebral hemorrhage. 24 total subjects\n      will be randomly assigned to minocycline or control (1:1). The first dose will be given\n      intravenously. Subsequent doses will be given orally every 24 hours for a total of five\n      doses. The study will test to see if the medication is safe in intracerebral hemorrhage.\n      The pharmacokinetics of minocycline in intracerebral hemorrhage will be determined and the\n      impact of minocycline on blood biomarkers."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age or older.\n\n          -  Intracerebral hemorrhage documented by CT scan\n\n          -  The first dose of the drug can be administered within 6 hours of time last known to\n             be at baseline\n\n        Exclusion Criteria:\n\n          -  Allergy to tetracycline antibiotics\n\n          -  Pregnancy or suspected pregnancy (pregnancy test will be done on women of\n             child-bearing potential)\n\n          -  Hepatic and/or renal insufficiency (LFT's >3x upper limit of normal; Creatinine\n             >2mg/dL)\n\n          -  History of intolerance to minocycline\n\n          -  National Institutes of Health Stroke Scale score of 4 or less\n\n          -  Glasgow Coma Scale score of 5 or less\n\n          -  Surgical evacuation of hematoma planned within 24 hours\n\n          -  Secondary intracerebral hemorrhage resulting from trauma, arteriovenous malformation,\n             aneurysm, tumor or other causes\n\n          -  Thrombocytopenia (platelet count <75,000/mm3) or coagulopathy (INR >1.4)\n\n          -  Previously not independent (prestroke modified Rankin scale score >2)\n\n          -  Suspected of not being able to comply with the study protocol\n\n          -  Unlikely to be available for 90 day follow-up\n\n          -  Pre-existing Do Not Resuscitate (DNR) order or indication that a new DNR order will\n             be implemented within the first 48 hours of hospitalization"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01805895", 
            "org_study_id": "Pro00000718"
        }, 
        "intervention": {
            "arm_group_label": "Minocycline", 
            "intervention_name": "Minocyline", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Minocycline"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Stroke", 
            "Acute Intracerebral Hemorrhage", 
            "Intracerebral Hemorrhage", 
            "Hemorrhagic stroke", 
            "Hemorrhage", 
            "Minocycline"
        ], 
        "lastchanged_date": "March 5, 2013", 
        "location": {
            "contact": {
                "email": "jswitzer@gru.edu", 
                "last_name": "Jeffrey Switzer, DO", 
                "phone": "706-721-1691"
            }, 
            "facility": {
                "address": {
                    "city": "Augusta", 
                    "country": "United States", 
                    "state": "Georgia", 
                    "zip": "30912"
                }, 
                "name": "Georgia Health Sciences University"
            }, 
            "investigator": [
                {
                    "last_name": "Jeffrey Switzer, DO", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "David Hess, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Askiel Bruno, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Fenwick Nichols, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Hartmut Gross, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Susan Fagan, PharmD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Minocycline in Acute Cerebral Hemorrhage (MACH) Trial", 
        "overall_contact": {
            "email": "jswitzer@gru.edu", 
            "last_name": "Jeffrey Switzer, DO", 
            "phone": "706-721-1691"
        }, 
        "overall_contact_backup": {
            "email": "mpark@gru.edu", 
            "last_name": "Mary Anne Park, RN", 
            "phone": "706-721-0193"
        }, 
        "overall_official": {
            "affiliation": "Georgia Regents University", 
            "last_name": "Jeffrey Switzer, DO", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "A blinded assessor will perform the modified Rankin Scale after 90 days to determine functional outcome. This will serve as our efficacy endpoint.", 
                "measure": "modified Rankin Scale", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }, 
            {
                "description": "Adverse events will be assessed for 90 days. This will serve as our safety endpoint.", 
                "measure": "Safety assessment", 
                "safety_issue": "Yes", 
                "time_frame": "90 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01805895"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Georgia Regents University", 
        "sponsors": {
            "collaborator": {
                "agency": "American Heart Association", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Georgia Regents University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}